These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 21777664)

  • 1. Development and characterization of a new thief sampling device for cohesive powders.
    Susana L; Canu P; Santomaso AC
    Int J Pharm; 2011 Sep; 416(1):260-7. PubMed ID: 21777664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the influence of powder flowability, fluidization and de-agglomeration characteristics on the aerosolization of pharmaceutical model powders.
    Zhou QT; Armstrong B; Larson I; Stewart PJ; Morton DA
    Eur J Pharm Sci; 2010 Aug; 40(5):412-21. PubMed ID: 20433919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved understanding of factors contributing to quantification of anhydrate/hydrate powder mixtures.
    Rantanen J; Wikström H; Rhea FE; Taylor LS
    Appl Spectrosc; 2005 Jul; 59(7):942-51. PubMed ID: 16053567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the grinding behaviour in a single particle impact device: studies on pharmaceutical powders.
    Meier M; John E; Wieckhusen D; Wirth W; Peukert W
    Eur J Pharm Sci; 2008 May; 34(1):45-55. PubMed ID: 18400475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The determination of the Enslin number].
    Zessin G; Kala H
    Pharmazie; 1984 May; 39(5):327-9. PubMed ID: 6473493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of sampling techniques for in-line monitoring using Raman spectroscopy.
    Wikström H; Lewis IR; Taylor LS
    Appl Spectrosc; 2005 Jul; 59(7):934-41. PubMed ID: 16053566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the effect of lactose particle size on the properties of DPI formulations using experimental design.
    Guenette E; Barrett A; Kraus D; Brody R; Harding L; Magee G
    Int J Pharm; 2009 Oct; 380(1-2):80-8. PubMed ID: 19596428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving flow properties of ibuprofen by fluidized bed particle thin-coating.
    Ehlers H; Räikkönen H; Antikainen O; Heinämäki J; Yliruusi J
    Int J Pharm; 2009 Feb; 368(1-2):165-70. PubMed ID: 19010403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sampling and characterization of pharmaceutical powders and granular blends.
    Muzzio FJ; Goodridge CL; Alexander A; Arratia P; Yang H; Sudah O; Mergen G
    Int J Pharm; 2003 Jan; 250(1):51-64. PubMed ID: 12480273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass-balanced blend uniformity analysis of pharmaceutical powders by at-line near-infrared spectroscopy with a fiber-optic probe.
    Li W; Johnson MC; Bruce R; Ulrich S; Rasmussen H; Worosila GD
    Int J Pharm; 2006 Dec; 326(1-2):182-5. PubMed ID: 16920283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different modes of dynamic image analysis in monitoring of pharmaceutical dry milling process.
    Nalluri VR; Schirg P; Gao X; Virdis A; Imanidis G; Kuentz M
    Int J Pharm; 2010 May; 391(1-2):107-14. PubMed ID: 20188807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dry powder inhaler formulation.
    Telko MJ; Hickey AJ
    Respir Care; 2005 Sep; 50(9):1209-27. PubMed ID: 16122404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development of DMA for the detection of amorphous content in pharmaceutical powdered materials.
    Royall PG; Huang CY; Tang SW; Duncan J; Van-de-Velde G; Brown MB
    Int J Pharm; 2005 Sep; 301(1-2):181-91. PubMed ID: 16026947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An experimental/computational approach for examining unconfined cohesive powder flow.
    Faqih A; Chaudhuri B; Alexander AW; Davies C; Muzzio FJ; Silvina Tomassone M
    Int J Pharm; 2006 Nov; 324(2):116-27. PubMed ID: 16926074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low powder mass filling of dry powder inhalation formulations.
    Eskandar F; Lejeune M; Edge S
    Drug Dev Ind Pharm; 2011 Jan; 37(1):24-32. PubMed ID: 20738180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the performance of two sample thieves for the determination of the content uniformity of a powder blend.
    Garcia TP; Taylor MK; Pande GS
    Pharm Dev Technol; 1998 Feb; 3(1):7-12. PubMed ID: 9532595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cohesive, multicomponent, dense powder flow characterization by NIR.
    Benedetti C; Abatzoglou N; Simard JS; McDermott L; Léonard G; Cartilier L
    Int J Pharm; 2007 May; 336(2):292-301. PubMed ID: 17240094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sampling bias in blending validation and a different approach to homogeneity assessment.
    Kraemer J; Svensson JR; Melgaard H
    Drug Dev Ind Pharm; 1999 Feb; 25(2):217-22. PubMed ID: 10065355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of segregation tendency in dry particulate pharmaceutical mixtures: Application of an adapted mathematical tool to cohesive and non-cohesive mixtures.
    Abatzoglou N; Simard JS
    Pharm Dev Technol; 2010; 15(2):113-23. PubMed ID: 19580377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melt granulation of pharmaceutical powders: a comparison of high-shear mixer and fluidised bed processes.
    Passerini N; Calogerà G; Albertini B; Rodriguez L
    Int J Pharm; 2010 May; 391(1-2):177-86. PubMed ID: 20214959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.